home All News open_in_new Read More

OBI Pharma Enters Collaboration with GlyTech to Expand GlycOBI® Enabling Technologies Outreach in Japan and to Advance Glycan Production

TAIPEI, Taiwan, Dec. 23, 2024 (GLOBE NEWSWIRE) — OBI Pharma, Inc. (OBI), a clinical-stage global oncology company specialized in the development of novel cancer therapies such as antibody-drug conjugates (ADC) and active immunotherapies (4174. TWO), and GlyTech, Inc. (GlyTech), a Japan manufacturer that focuses on glycan production and chemical glycosylation technologies, have entered into a […]

today 10 hours ago attach_file Other
attach_file Technology
attach_file Events
attach_file Culture
attach_file Other
attach_file Politics
attach_file Culture
attach_file Events
attach_file Other
attach_file Culture
attach_file Other


ID: 9249997
Add Watch Country

arrow_drop_down